Learn about the clinical approach to toxic exposure and its role in enhancing patient care and safety measures.

Educational Abstract: Integrative, Evidence-Based Toxicology Care From Emergency Stabilization To Functional Recovery

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this comprehensive educational post, I guide you through a clear, evidence-based roadmap for recognizing, stabilizing, and treating toxic exposures and ingestions across emergency, ICU, and integrative injury-care settings. Drawing on contemporary toxicology research, frontline clinical practice, and multidisciplinary collaboration, I explain:

• The physiologic logic behind toxidromes and how to identify them at the bedside
• Practical decontamination strategies and when GI interventions add value
• Antidotes and reversal strategies for organophosphates, anticholinergics, sympathomimetics (e.g., cocaine, methamphetamine), opioids, tricyclic antidepressants, ethylene glycol, acetaminophen, cyanide, and salicylates
• Advanced protocols: high-dose naloxone, insulin therapy, lipid emulsion (intralipid), cyproheptadine for serotonin syndrome, octreotide for sulfonylurea hypoglycemia, and precision anticoagulant reversal
• Airway-first principles in severe metabolic acidosis and DKA, including ventilation matching
• How integrative chiropractic care fits safely into a medically directed toxicology workflow with functional medicine, rehabilitation, and personal injury care
• The team-based approach at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I practice with our Medical Director and Collaborative Physician, Maria Guadalupe Cardenas, MD (Board Certified, Internal Medicine; NPI #1164426749; Texas MD License #J2933), whose 40+ years of internal medicine expertise guide safety, diagnostics, and pharmacologic oversight

I present modern, evidence-based methods and highlight clinical observations from my practice and shared resources at sciatica. clinic and my professional updates on LinkedIn. The goal is simple: make complex toxic emergencies understandable and actionable, while showing how a multidisciplinary, integrative model improves outcomes.

Integrative Toxicology Care Model: Medical Direction Meets Chiropractic And Functional Recovery

I practice at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas. Our multidisciplinary setup is common in integrative and injury care clinics and is built on the principle that complex cases benefit from coordinated expertise:

• Medical Direction and Oversight (Dr. Cardenas)

• • Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933
  • 40+ years of experience directing diagnostics, antidote selection, pharmacologic safety, and escalation decisions

• Chiropractic Care (Dr. Jimenez)

• • Neuromusculoskeletal recovery, autonomic regulation, respiratory mechanics optimization, and pain modulation

• Functional Medicine

• • Nutrition, detoxification capacity, mitochondrial health, endocrine function, inflammation, and microbiome support

• Personal Injury Care

• • Documentation, case management, occupational/environmental exposure tracking, and rehabilitation pathways

• Rehabilitation Services

• • Physical therapy, graded exercise, neurodynamic techniques, and mobility restoration

Our model is MD-directed, chiropractor-integrated, functionally informed, and rehab-supported—particularly effective when patients face toxic exposures that require acute stabilization followed by long-term recovery. The coordination ensures the right interventions at the right time, with appropriate safety checks.

Foundations Of Toxicology: Physiology, Priorities, And Practical Steps

Understanding toxicology begins with physiology. Each antidote and protocol maps to a specific receptor, enzyme, channel, or cellular pathway.

Physiology First: How Toxins Disrupt Systems

• Receptors and Channels

• • Muscarinic and nicotinic acetylcholine receptors govern autonomic signaling; overstimulation leads to secretions, bradycardia, fasciculations, and weakness (WHO, n.d.)
  • GABA-A and NMDA receptors are central to inhibitory and excitatory CNS control; sedative-hypnotics depress, excitotoxins provoke
  • Sodium and potassium channels drive cardiac conduction; blockade widens QRS and predisposes to ventricular arrhythmias (EMCrit Project, n.d.)

• Key Enzymes

• • Acetylcholinesterase inhibition by organophosphates generates cholinergic crises.
  • Alcohol dehydrogenase (ADH) converts ethylene glycol and methanol into toxic acids (NEJM, n.d.)

• Transport and pH

• • Weak acids/bases change ionization with pH shifts; bicarbonate reduces cardiotoxicity via conduction effects and protein binding (EMCrit Project, n.d.)

• Volume of Distribution & Protein Binding

• • Dialysis, intralipid, or charcoal efficacy depends on solubility, binding, and distribution characteristics (ACMT, n.d.; UpToDate, n.d.)

Primary Assessment: ABCs Lead The Way

• Airway

• • Protect against aspiration and obstruction, especially with hypersecretions (cholinergic crises) or depressed mental status (opioids/sedatives)

• Breathing

• • Watch for hypoventilation (opioids), bronchorrhea (organophosphates), hyperventilation (salicylates)

• Circulation

• • Manage hypotension (sedatives/TCA overdose) or hypertensive crises (sympathomimetics); early EKG for conduction delay.s

• Glucose

• • Immediate fingerstick; toxins and therapies (e.g., insulin therapy) alter glucose levels

• Temperature

• • Treat hyperthermia aggressively to prevent organ damage

I often initiate benzodiazepines early for agitation, seizures, or severe sympathetic activation—reducing catecholaminergic surges, improving myocardial oxygen balance, and protecting neurologic function (Wightman & Nelson, 2022).

Decontamination: What Works, WhaDoesn’t’t, And When To Use It

Dermal And Inhalational Decontamination

• Water irrigation is usually sufficient; avoid agents that increase dermal penetration.
• Proper PPE for organophosphate exposure to prevent secondary contamination (WHO, n.d.)
• Remove from source; provide supplemental oxygen; consider bronchodilators for bronchospasm.m

Gastrointestinal Decontamination

• Induced emesis is no longer recommended (ACMT, n.d.)
• Gastric lavage has limited indications and requires airway protection
• Activated charcoal (UpToDate, n.d.)

• • Most effective within 4 hours for adsorbable compounds
  • Avoid in unprotected airways; intubate first if needed
  • Poor efficacy for iron, lithium, alcohols, caustics, and some heavy metals

• Whole bowel irrigation (PEG)

• • Useful for body packers/stuffers and sustained-release or charcoal-inaccessible toxins (ACMT, n.d.)

• Hemodialysis

• • Effective for small, water-soluble, low protein-binding toxins like ethylene glycol, methanol, sometimes salicylates (NEJM, n.d.)
  • Not useful for highly protein-bound, lipophilic drugs (e.g., TCAs), but corrects severe acid-base disturbances

These choices hinge on time since ingestion, substance properties, airway status, and hemodynamic stability.

Anticholinergic Toxidrome: Recognition And Management

Clinical Pattern

• Blind as a bat (mydriasis, blurred vision)
• Red as a beet (flushed skin)
• Hot as a hare (hyperthermia)
• Dry as a bone (anhidrosis, dry mucosa)
• Mad as a hatter (delirium, agitation, psychosis)
• Full as a flask (urinary retention)
• EKG may reveal wide QRS (>100 ms) with sodium-channel blockade in TCA overdoses (EMCrit Project, n.d.)

Common Agents

• Anticholinergics (atropine, scopolamine)
• Antihistamines (diphenhydramine, doxylamine)
• Psychotropics (TCAs, antipsychotics)
• Plants (jimsonweed)

WhIt’s’s Dangerous

• Depressed sweating, impaired heat dissipation, tachycardia, and conduction slowing via fast sodium channel blockade (TCAs) raise risk of ventricular arrhythmias.

Management

• Airway/Breathing: Intubate if needed; correct acidosis
• Seizures/Agitation: Benzodiazepines first-line
• Perfusion: IV fluids; norepinephrine if needed
• Activated charcoal if early and airway protected
• Systemic alkalinization with sodium bicarbonate infusion to narrow QRS and reduce arrhythmias (EMCrit Project, n.d.)
• Cooling for hyperthermia
• Physostigmine can be considered under expert guidance, excluding TCA overdose; requires EKG monitoring

Cholinergic Crisis: Organophosphate And Carbamate Poisoning

Pathophysiology

Acetylcholinesterase inhibition causes acetylcholine accumulation:

• Muscarinic overstimulation: SLUDGE/DUMBELS—salivation, lacrimation, urination, diarrhea, GI cramping, emesis, bronchorrhea, bronchospasm, bradycardia, miosis
• Nicotinic overstimulation: Fasciculations, weakness, paralysis—especially diaphragm involvement (WHO, n.d.)

Clinical Priorities

• Decontamination: Remove clothing, copious water irrigation; strict PPE
• Airway: Elevate head-of-bed, suction secretions, early intubation if needed
• Seizures: Benzodiazepines first-line

Antidotes

• Atropine

• • Blocks muscarinic receptors, reducing secretions
  • Titrate 2–5 mg IV every 3–5 minutes; endpoint is drying of secretions and improved ventilation

• Pralidoxime (2-PAM)

• • Reactivates acetylcholinesterase by removing the organophosphate
  • Give early to prevent irreversible aging; consider continuous infusion (WHO, n.d.)

Monitor for intermediate syndrome—delayed neuromuscular weakness post-stabilization.

Sympathomimetic Toxicity: Cocaine, Methamphetamine, Amphetamines

WhatYou’lll See

• Euphoria, restlessness, paranoia, agitation, psychosis
• Mydriasis, tachycardia, hypertension, hyperthermia
• Diaphoresis—key differentiator from anticholinergic toxicity (hot and wet vs hot and dry)
• Severe complications: coronary vasospasm, arrhythmias, seizures, rhabdomyolysis, stroke (AHA, n.d.)

Management

• Benzodiazepines to reduce central sympathetic outflow
• Vasodilators (nitroprusside, nicardipine, nitroglycerin) for severe hypertension or vasospasm
• Avoid pure beta-blockers (e.g., metoprolol) due to unopposed alpha; consider labetalol or prioritize vasodilators (AHA, n.d.)
• Cooling to prevent rhabdomyolysis
• Hydration, CK/renal monitoring
• Activated charcoal if ingestion and protected airway
• Whole bowel irrigation for body packers/stuffers
• Sodium bicarbonate for wide QRS due to sodium-channel blockade (EMCrit Project, n.d.)

Continuous cardiac monitoring and serial EKGs guide risk.

Opioid Toxicity And High-Dose Naloxone: Breathing Comes First

Presentation

Opioids depress brainstem respiratory centers, causing hypoventilation, hypercapnia, hypoxemia; miosis is common but not universal.

Naloxone Strategy

• Start low if withdrawal risk is high in chronic users; prioritize ventilation in apnea.a
• High-dose naloxone escalation may be necessary for synthetic opioids (fentanyl analogs); repeated boluses or infusion due to short naloxone half-life (CDC, n.d.)
• Airway support: Bag-valve mask, oxygen, intubation if inadequate response

Monitor for rebound respiratory depression and pulmonary edema; consider infusion for long-acting agents.

Acetaminophen Toxicity: Timing, Staging, And N-Acetylcysteine

Key Timing

• First ideal level at 4 hours post-ingestion; earlier draws can be falsely reassuring
• If time is unknown, draw on arrival and again at 4 hours (National Library of Medicine, n.d.)

Why N-acetylcysteine (NAC) Works

• Replenishes glutathione, detoxifying NAPQI—the hepatotoxic metabolite
• Protects hepatocytes; earlier administration improves outcomes (Heard, 2008)

Use the Rumack–Matthew nomogram for single acute ingestions; start NAC for delayed presentations with elevated transaminases or prolonged ingestion profiles. Monitor LFTs, INR, bilirubin, renal function, and mental status.

Ethylene Glycol And Toxic Alcohols: Crystals, Acidosis, And ADH Blockade

Clinical Clues

• Early CNS depression; later anion gap metabolic acidosis
• Calcium oxalate crystals in urine; risk of renal failure
• Methanol causes optic nerve injury and severe acidosis; isopropanol causes ketosis without acidosis

Pathophysiology

• Ethylene glycol is metabolized via ADH to glycolic acid and oxalic acid
• Oxalic acid complexes with calcium, forming calcium oxalate crystals and damaging renal tubules (NEJM, n.d.)

Management

• Fomepizole: Potent ADH inhibitor—halts toxic metabolite production
• Ethanol: Historical competitive inhibitor when fomepizole unavailable
• Hemodialysis: Removes parent compounds and metabolites; corrects severe acidosis/electrolytes
• Bicarbonate: Supports pH and reduces cardiac irritability
• Correct hypocalcemia cautiously; treat symptomatic cases

Early ADH blockade prevents renal failure and systemic complications.

Sodium Channel Blockade And Sodium Bicarbonate: Electrical Rationale

EKG Patterns

• Wide QRS (>100 ms)
• Rightward axis and terminal R wave in aVR
• Risk of ventricular arrhythmias (EMCrit Project, n.d.)

Why Bicarbonate Helps

• Alkalinizes serum to reduce drug binding to sodium channels
• Increases protein binding, reducing active free drug
• Narrows QRS and improves conduction velocity

Use bolus plus infusion strategies, monitoring pH, potassium, and EKG changes. Titrate to effect (often pH 7.45–7.55).

Lipid Emulsion Therapy (Intralipid): The”“Lipid Sink” For Cardiotoxic Emergencies

Indications

• Local anesthetic systemic toxicity (LAST) (bupivacaine)
• Lipophilic cardiotoxins: some TCAs, verapamil/diltiazem, beta-blockers, quetiapine, others (EMRA, n.d.)

Mechanism

• Lipid sink: Sequesters lipophilic toxins from myocardium/CNS, reducing free active drug
• Provides fatty acids to support myocardial contractility

Protocol Considerations

Administer per dosing guidelines; monitor for pancreatitis, fat overload, and lab assay interference. Use adjunctively with ACLS, vasopressors, bicarbonate, or HIET depending on toxin.

High-Dose Insulin Euglycemia Therapy (HIET): Severe Beta-Blocker And CCB Overdose

When To Use

• Cardiogenic shock from beta-blockers or calcium channel blockers (Levine et al., 2021; Shepherd & Velez, 2018)

How It Works

• Improves myocardial inotropy and carbohydrate utilization
• Facilitates glucose transport into myocytes
• Requires dextrose infusion and frequent glucose/potassium monitoring

Combine with vasopressors, calcium, glucagon (beta-blocker), lipid emulsion, and bicarbonate if conduction slows.

Cyanide And Carbon Monoxide: Inhalational Toxins And Cellular Hypoxia

Cyanide Poisoning: A Cellular Asphyxiant

• Source: Combustion of synthetic materials (fires), industrial exposures
• Mechanism: Inhibits cytochrome c oxidase (complex IV) in mitochondria—blocks oxidative phosphorylation, causes histotoxic hypoxia and profound lactic acidosis
• Clinical imperative: Do not delay treatment for labs in suspected cases; manage airway and acidosis aggressively

Antidote Evolution

• Historical cyanide kits (nitrites + sodium thiosulfate) induced methemoglobinemia—now largely obsolete
• Hydroxocobalamin is first-line: binds cyanide to form cyanocobalamin (vitamin B12) for renal excretion; causes benign reddish skin and dark red urine (Lawson-Smith et al., 2011)

Carbon Monoxide Poisoning: Deceptive Oxygenation

• Pulse oximetry and PaO2 can appear normal; definitive test is CO-oximetry for carboxyhemoglobin (COHb%) (Rose et al., 2017)
• Mechanism: CO binds hemoglobin with 200–250x higher affinity than oxygen and shifts the dissociation curve left, reducing tissue oxygen delivery
• Treatment: 100% high-flow oxygen; consider hyperbaric oxygen (HBO) for severe cases, LOC, pregnancy, or end-organ injury (Weaver et al., 2002; Hampson et al., 2012)

Salicylate Toxicity: Uncoupled Oxidative Phosphorylation And Mixed Acid-Base Disorder

Pathophysiology

• Uncouples oxidative phosphorylation—energy loss as heat, leading to hyperthermia
• Produces high anion gap metabolic acidosis; direct medullary stimulation causes primary respiratory alkalosis, resulting in a mixed disorder (O’Malley, 2007)

Clinical Spectrum

• Tinnitus (classic early sign), nausea, vomiting
• Kussmaul respirations, hyperthermia, confusion
• Risk of non-cardiogenic pulmonary edema and ARDS

Management

• Airway protection, aggressive cooling, fluids
• Activated charcoal if early and airway protected
• Urinary alkalinization with sodium bicarbonate:

• Typical regimen: 3 amps bicarbonate in 1 L D5W, target urine pH ≥ 7.5, serum pH 7.45–7.55
• Potassium repletion is essential to enable renal ion trapping (Molloy et al., 2019)

• Hemodialysis for severe toxicity, renal failure, refractory acidosis, or coma (Choi et al., 2010)

Serotonin Syndrome: Differentiation And Targeted Therapy

Recognition

• Agitation, tachycardia, hypertension, hyperthermia, hyperreflexia, clonus, myoclonus
• Triggers: SSRIs, MAOIs, polypharmacy (including John’s Wort), drug interactions

Differentiation From NMS

• Serotonin syndrome: hyperreflexia/clonus; rapid onset
• NMS: lead-pipe rigidity, bradyreflexia; slower onset

Management

• Benzodiazepines for agitation and seizure control
• Aggressive cooling; antipyretics are ineffective
• Cyproheptadine (oral) as a serotonin antagonist when enteral route is available (Boyer & Shannon, 2005)

Sulfonylurea-Induced Hypoglycemia: Octreotide And Disposition

Problem

Sulfonylureas stimulate pancreatic insulin release, causing prolonged hypoglycemia (12–24 hours).

Management

• Dextrose infusion with frequent glucose checks
• Octreotide (somatostatin analog) to suppress insulin secretion in refractory or recurrent hypoglycemia (Huang & Unger, 2006)
• Admission/observation to prevent unsafe discharge

Anticoagulant Reversal: Heparin, Warfarin, And DOAC Precision

Heparin

• Protamine neutralizes unfractionated heparin; partial effect on enoxaparin; dosing precision to avoid hypotension or paradoxical effects (McLean, 2012)

Warfarin

• Vitamin K plus four-factor PCC (e.g., Kcentra, Focsar) or plasma to restore factors II, VII, IX, X—PCC preferred for speed and low volume (Sarode et al., 2013)

DOACs

• Dabigatran: Idarucizumab—monoclonal fragment antidote
• Rivaroxaban/apixaban: Andexanet alfa—decoy factor Xa (Connolly et al., 2019)
• Edoxaban: Andexanet may be considered off-label; many centers use four-factor PCC when specific reversal is unavailable or unaffordable

Benzodiazepine Overdose: Flumazenil With Caution

Risks And Use Cases

• Flumazenil can precipitate withdrawal seizures in chronic users
• Appropriate for pediatric accidental ingestions or procedural sedation reversal in monitored settings
• Avoid in mixed overdoses where reversing benzodiazepines can unmask pro-convulsants

Vasopressor Extravasation: Phentolamine Rescue And Tissue Preservation

Protocol

• Stop infusion; keep catheter in place; inject phentolamine through the line and perilesional tissue.
• Alpha-blockade reverses local vasoconstriction, preventing necrosis
• Warm compresses, elevation; consider plastic surgery input (Kahn et al., 2002)

Airway Management In Severe Metabolic Acidosis And DKA: Ventilation Matching Saves Lives

Why Ventilation Matching Matters

• In metabolic acidosis, patients hyperventilate to reduce PaCO2, buffering pH
• Intubation with inadequate ventilation can raise PaCO2, collapse pH, and precipitate cardiac arrest

Clinical Approach

• Avoid intubation if airway reflexes and ventilatory drive are intact
• If unavoidable:

• • Match pre-intubation minute ventilation with high RR and appropriate tidal volume
  • Use ETCO2 and ABGs to keep PaCO2 near pre-intubation values
  • Avoid prolonged paralysis; maintain aggressive ventilation until acidosis improves (Kellum & Elbers, 2018)

DKA Specifics

• Preserve Kussmaul respirations when possible
• Correct dehydration, hyperglycemia, and electrolytes while maintaining ventilatory compensation (Wolfsdorf et al., 2018; Kitabchi et al., 2009)

Toxidrome Recognition: A Bedside Pattern Approach

Pattern Highlights

• Anticholinergic: Hot/dry skin, delirium, urinary retention, decreased bowel sounds; QRS may widen with TCAs
• Sympathomimetic: Hot/wet (diaphoresis), agitation, hypertension, tachycardia, chest pain risk; hyperthermia and rhabdo
• Cholinergic: Profuse secretions, bradycardia, wheezing, miosis, diarrhea; muscle weakness raises respiratory failure risk
• Opioid: Depressed respirations, miosis (not universal); responds to naloxone
• Sedative-Hypnotic: CNS depression without typical pupillary findings; watch for respiratory compromise
• Sodium-channel blockade: Wide QRS—administer sodium bicarbonate

Case Reasoning: Applying Physiology At The Bedside

Pediatric Unknown Ingestion With Seizures And Hyperthermia

• Dilated pupils, tachycardia, dry skin, wide QRS: Anticholinergic toxidrome with sodium-channel blockade—likely TCA or potent antihistamine
• Immediate steps:

• • Airway protection; consider intubation
  • Benzodiazepines for seizures/agitation
  • 12-lead EKG to quantify QRS
  • Sodium bicarbonate bolus/infusion
  • Activated charcoal if early and airway secure
  • Cooling measures
  • Fluids; norepinephrine if hypotensive

Adult Chest Pain After Suspected Cocaine Use

• Differentiate via diaphoresis (sympathomimetic)
• Management:

• • Benzodiazepines and vasodilators (nitrates, nicardipine)
  • Avoid metoprolol; consider labetalol if necessary
  • Treat hyperthermia and hydrate; monitor for ischemia and arrhythmias

Organophosphate Exposure

• Expect SLUDGE/DUMBELS with copious secretions and wheeze
• Actions:

• • PPE, dermal decontamination, airway management
  • Atropine titrated to dry secretions
  • Early 2-PAM
  • Benzodiazepines for seizures; monitor for intermediate syndrome

Ethylene Glycol Ingestion

• Calcium oxalate crystals, anion gap acidosis, renal risk
• Therapy:

• • Fomepizole, hemodialysis, bicarbonate
  • Monitor electrolytes and kidney function

Acetaminophen Ingestion

• 4-hour level determines risk; NAC protects liver via glutathione
• Serial labs; adjust protocols for sustained-release or staggered ingestions

Integrative Chiropractic Care Within Medically Directed Toxicology

After acute stabilization, chiropractic care integrates safely to accelerate recovery, always under medical oversight by Dr. Cardenas.

Where Chiropractic Fits

• Autonomic Regulation

• • Gentle, targeted manual therapies to improve vagal tone, reduce sympathetic overdrive, and support heart rate variability—especially useful after stimulant-induced hyperadrenergic states

• Respiratory Mechanics

• • Thoracic mobilization and rib mechanics optimization to improve ventilatory efficiency post-intubation or after bronchorrhea-related compromise

• Neuromuscular Rehabilitation

• • Progressive mobilization to restore motor control, balance, and strength after neuromuscular weakness or ICU deconditioning

• Pain Modulation

• • Non-pharmacologic approaches to reduce musculoskeletal pain from seizures, restraints, or prolonged immobilization—lowering opioid reliance

• Lymphatic And Circulatory Support

• • Techniques that encourage lymphatic flow may help reduce inflammatory edema.

All interventions are staged after hemodynamic and respiratory stability, aligned with medication profiles, and tailored to contraindications (e.g., avoid manipulative thrusts in hemodynamic instability, coagulopathy, or fractures).

Functional Medicine Synergy

• Detoxification Capacity

• • Assess phase I/II hepatic pathways, glutathione status, and nutrient cofactors (B-vitamins, magnesium, selenium) that influence recovery post-NAC or oxidative stress.s

• Mitochondrial Health

• • Targeted nutrition and graded exercise to restore electron transport, reduce ROS

• Endocrine And Metabolic Balance

• • Treat dysglycemia following HIET; optimize insulin sensitivity and adrenal function.

• Inflammation And Microbiome

• • Address systemic inflammation and GI consequences; repair mucosal integrity when caustics or antibiotics were involved.d

This synergy supports comprehensive recovery beyond the antidote window.

Team-Based Care: Roles, Coordination, And Safety

• Dr. Maria Guadalupe Cardenas, MD—Medical Director and Collaborative Physician

• • Oversees diagnostics, antidotes, pharmacologic safety, and medical safety
  • Coordinates referrals to nephrology, cardiology, pulmonology, neurology, ED/ICU as needed

• Dr. Alex Jimenez, DC, APRN, FNP-BC

• • Integrates chiropractic care with medical protocols
  • Provides advanced practice nursing assessments; coordinates functional medicine and rehabilitation

• Rehabilitation Team

• • Physical therapy, exercise physiology, massage therapy for mobility, strength, pain management

• Case Management

• • Ensures continuity for personal injury, workplace exposures, and documentation

Communication is constant. We reconcile medications and supplements, monitor labs and vitals during functional interventions, and ensure seamless transitions from acute stabilization to rehab.

Practical Protocol Pearls: Rapid Reference For Clinicians

• Always obtain a 12-lead EKG in suspected cardiotoxic ingestions; it guides bicarbonate, lipid, and HIET decisions (EMCrit Project, n.d.)
• Methamphetamine hypertensive crises: Choose benzodiazepines and vasodilators; avoid pure beta-blockers like metoprolol (AHA, n.d.)
• Anticholinergic toxidrome with wide QRS: Prioritize bicarbonate; add activated charcoal if early and airway safe
• Organophosphate poisoning: Titrate atropine to dry; start 2-PAM early; decontaminate meticulously (WHO, n.d.)
• Acetaminophen overdose: Draw first ideal level at 4 hours; initiate NAC promptly (National Library of Medicine, n.d.)
• Ethylene glycol: Use fomepizole; consider hemodialysis; watch for calcium oxalate crystals and anion gap acidosis (NEJM, n.d.)
• Lipophilic cardiotoxins with refractory shock: Consider lipid emulsion therapy (EMRA, n.d.)

Rehabilitation And Recovery: From Stabilization To Strength

Once patients are stabilized, we restore function:

• Breathing

• • Diaphragmatic exercises, thoracic mobility work, posture corrections to improve ventilation and reduce dyspnea

• Strength And Endurance

• • Graded resistance and aerobic plans to rebuild mitochondrial capacity and autonomic stability

• Pain And Neuromuscular Control

• • Manual therapy, neurodynamic techniques, sensorimotor retraining to reduce pain and improve movement quality

• Nutrition

• • Emphasize protein adequacy, micronutrients for hepatic and mitochondrial support, and hydration to maintain renal function post-toxin

All care is individualized, medically supervised, and aligned with patient goals.

Patient Education And Safety: Preventing Re-Exposure And Supporting Recovery

We educate patients on:

• Avoiding re-exposure and recognizing early warning signs
• Safe storage and dosing of OTC and prescription medications
• Importance of follow-up labs and cardiac monitoring
• Heat illness prevention and hydration for stimulant histories
• Access to addiction services and mental health support

Education improves adherence and outcomes.

Clinical Observations From Practice: Lessons At The Intersection Of Toxicology And Rehab

From my clinical work and the shared insights at Sciatica clinic and my updates on LinkedIn, I consistently observe:

• Sympathomimetic hyperthermia responds best to early benzodiazepines plus proactive cooling; delaying cooling increases rhabdomyolysis risk
• Anticholinergic delirium often improves with environmental optimization—low light, minimal stimuli—alongside benzodiazepines and bicarbonate when indicated.
• Opioid rebound after naloxone is common with long-acting agents; low-dose infusion prevents repeated apnea events.s
• Organophosphate recovery can be non-linear; intermediate syndrome requires vigilant neuromuscular monitoring.
• Post-ICU patients benefit from thoracic and cervical mobilization, diaphragmatic retraining, and graded exercise, accelerating return to baseline function and decreasing pai.n

In musculoskeletal recovery, I find that restoring thoracic mobility and rib mechanics improves breathing and autonomic balance—indirectly reducing pain sensitivity in patients recovering from complex toxicologic crises. Optimizing pelvic-lumbar stability reduces reliance on accessory breathing and enhances diaphragmatic function. Improving cervicothoracic junction mobility supports vagal tone and perceived anxiety reduction—a valuable element in post-serotonin syndrome or post-ICU states.

Integrative Insights: Why Each Technique Is Used And How It Fits

• Ventilation matching in acidosis.

• • Prevents PaCO2 rise and pH collapse by preserving respiratory compensation (Kellum & Elbers, 2018)

• Urinary alkalinization in salicylate toxicity

• • Enhances ion trapping and renal excretion; requires adequate potassium (Molloy et al., 2019)

• NAC in acetaminophen toxicity

• • Restores glutathione, neutralizes NAPQI, protects hepatocytes (Heard, 2008; Rumack & Matthew, 1975)

• Benzodiazepines in serotonin syndrome

• • Reduce CNS hyperexcitability; cyproheptadine blocks serotonergic receptors (Boyer & Shannon, 2005)

• Octreotide in sulfonylurea hypoglycemia

• • Suppresses insulin release; stabilizes glucose (Huang & Unger, 2006)

• Protamine for heparin

• • Acid-base binding neutralizes heparin; precise dosing avoids hypotension and paradoxical effects (McLean, 2012)

• Four-factor PCC for warfarin/DOAC-related bleeding

• • Rapid factor replacement with reduced volume vs plasma; idarucizumab and andexanet as drug-specific antidotes (Sarode et al., 2013; Connolly et al., 2019)

• Flumazenil caution

• • Avoid precipitating withdrawal seizures; reserve for select scenarios

• Phentolamine for vasopressor extravasation

• • Alpha-blockade reverses local vasoconstriction, preventing necrosis (Kahn et al., 2002)

• Activated charcoal/whole bowel irrigation

• • Adsorption and mechanical clearance reduce systemic absorption (ACMT, n.d.)

Conclusion: A Clear, Evidence-Based Path Through Toxic Emergencies And Recovery

Toxic exposures demand fast, physiologically informed decisions. The combination of:

• Rigorous primary assessment and airway-first logic
• Accurate toxidrome recognition
• Timely antidotes and advanced therapies (bicarbonate, HIET, lipid emulsion, cyproheptadine, octreotide, ADH blockade)
• Thoughtful decontamination
• Continuous monitoring for rebound and complications
• Medically directed integrative chiropractic, functional medicine, and rehabilitation

This helps create a comprehensive, modern approach that improves survival and speeds recovery. With Dr.Cardenas’ss medical direction and our integrated team at Injury Medical Clinic PA, we deliver coordinated, evidence-based care that meets patients where they are—from the emergency moment to full functional return.

References

• American College of Medical Toxicology: Position Statement on Gastric Decontamination (American College of Medical Toxicology, n.d.)
• Activated Charcoal: Efficacy and Limitations in Poisoning (UpToDate, n.d.)
• Organophosphate Poisoning: Clinical Features and Management (World Health Organization, n.d.)
• Naloxone Dosing in the Era of Synthetic Opioids (Centers for Disease Control and Prevention, n.d.)
• Management of Cocaine-Associated Chest Pain (American Heart Association, n.d.)
• High-Dose Insulin Euglycemia Therapy for Calcium Channel Blocker and Beta-Blocker Overdose (National Center for Biotechnology Information, n.d.)
• Lipid Emulsion Therapy in Toxicology (Emergency Medicine Residents’ Association, n.d.)
• Acetaminophen Toxicity and NAC Protocols (National Library of Medicine, n.d.)
• Ethylene Glycol Poisoning: Fomepizole and Dialysis (The New England Journal of Medicine, n.d.)
• Tricyclic Antidepressant Overdose and Sodium Bicarbonate Therapy (EMCrit Project, n.d.)
• Practice Recommendations in the Diagnosis, Management, and Prevention of Carbon Monoxide Poisoning (Hampson et al., 2012)
• Hydroxocobalamin for Cyanide Poisoning: The UK Experience (Lawson-Smith et al., 2011)
• Emergency Department Management of the Salicylate-Poisoned Patient (O’Malley, 2007)
• Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy (Rose et al., 2017)
• Hyperbaric Oxygen for Acute Carbon Monoxide Poisoning (Weaver et al., 2002)
• The Serotonin Syndrome (Boyer & Shannon, 2005)
• Acetylcysteine for Acetaminophen Poisoning (Heard, 2008)
• Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors (Connolly et al., Safety)
• Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate (Sarode et al., 2013)
• Octreotide for Sulfonylurea-Induced Hypoglycemia (Huang & Unger, 2006)
• Protamine Sulfate: Pharmacology and Clinical Use (McLean, 2012)
• Urinary Alkalinization in Salicylate Toxicity (Molloy et al., 2019)
• Acidosis and Ventilation in Critical Illness (Kellum & Elbers, 2018)
• Hyperglycemic Crises in Adult Patients with Diabetes (Kitabchi et al., 2009)
• ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic Ketoacidosis (Wolfsdorf et al., 2018)
• Management of Vasopressor Extravasation (Kahn et al., 2002)
• High-Dose Insulin Therapy in CCB and Beta-Blocker Overdose (Graul & Gomm, 2020)
• Cardiotoxicity of Calcium Channel and Beta Blockers (Levine et al., 2021)
• Advances in the Management of Poisoning (Wightman & Nelson, 2022)
• Acetaminophen Poisoning and Toxicity (Rumack & Matthew, 1975)
• Carbon Monoxide Poisoning: Practice and Prevention (Hampson et al., 2012)

In-text citations (APA-7 style): American College of Medical Toxicology (n.d.); Centers for Disease Control and Prevention (n.d.); Emergency Medicine Residents’ Association (n.d.); EMCrit Project (n.d.); National Center for Biotechnology Information (n.d.); National Library of Medicine (n.d.); The New England Journal of Medicine (n.d.); UpToDate (n.d.); World Health Organization (n.d.); Hampson et al. (2012); Lawson-Smith et al. (2011); O’Malley (2007); Rose et al. (2017); Weaver et al. (2002); Boyer & Shannon (2005); Heard (2008); Connolly et al. (2019); Sarode et al. (2013); Huang & Unger (2006); McLean (2012); Molloy et al. (2019); Kellum & Elbers (2018); Kitabchi et al. (2009); Wolfsdorf et al. (2018); Kahn et al. (2002); Graul & Gomm (2020); Levine et al. (2021); Wightman & Nelson (2022); Rumack & Matthew (1975).

SEO tags: toxicology, organophosphate poisoning, anticholinergic toxidrome, sympathomimetic toxicity, cocaine overdose, methamphetamine crisis, naloxone, high-dose insulin euglycemia therapy, lipid emulsion, intralipid, sodium bicarbonate therapy, tricyclic antidepressant overdose, acetaminophen toxicity, ethylene glycol ingestion, calcium oxalate crystals, activated charcoal, whole bowel irrigation, hemodialysis, cyanide poisoning, carbon monoxide poisoning, salicylate toxicity, ventilation matching, DKA airway management, serotonin syndrome, cyproheptadine, sulfonylurea hypoglycemia, octreotide, anticoagulant reversal, protamine, PCC, andexanet alfa, idarucizumab, benzodiazepine overdose, flumazenil risks, vasopressor extravasation, phentolamine rescue, integrative chiropractic care, functional medicine, rehabilitation, personal injury clinic, El Paso, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, sciatica clinic observations, LinkedIn clinical insights